ArticleCureus2024
Correlation Between Oxygen Desaturation Index Measured by Overnight Oximetry and Apnea-Hypopnea Index Measured by Polysomnography in Patients Diagnosed With Obstructive Sleep Apnea.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Diagnostic accuracy of biological markers for detecting obstructive sleep apnoea.The Cochrane database of systematic reviews · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background The most common sleep-disordered breathing (SBD) is obstructive sleep apnea (OSA), which affects nearly a billion adults worldwide. OSA is characterized by frequent episodes of a complete (apnea) or partial (hypopnea) collapse of the upper airway, mainly the oropharyngeal tract during sleep, with a consequent cessation or reduction of the airflow. Undiagnosed and untreated OSA can lead to cognitive and neurobehavioral dysfunction, cardiovascular comorbidities, inability to concentrate, memory impairment, and mood changes like irritability and depression, with a remarkable effect on quality of life. Polysomnography (PSG) remains the gold standard for diagnosis; however, it is expensive, less accessible, and has a long waiting period to get it done. Home nocturnal oximetry, measuring the oxygen desaturation index (ODI), is a promising alternative for diagnosis. Materials and methods A prospective observational study was conducted over two years, involving patients with a high pre-test probability of OSA. Patients underwent both home nocturnal oximetry and in-lab PSG. Statistical analysis was performed using the Spearman correlation, the Wilcoxon signed-rank test, and the receiver operating characteristic (ROC) curves to compare ODI and apnea-hypopnea index (AHI) values. Results Out of 67 participants, 43 (64%) had abnormal home oximetry results (ODI>5) and 62 (92.5%) had abnormal PSG (AHI>5). There was a significant correlation between ODI and AHI (r=0.734, p=0.001). No significant difference was found between ODI values from home oximetry and in-lab PSG. The sensitivity, specificity, and diagnostic accuracy of home oximetry in detecting OSA (ODI>5) were 69%, 100%, and 71%, respectively. The ROC analysis demonstrated an area under the curve (AUC) of 0.98 for predicting AHI>5. Conclusion Home nocturnal oximetry correlates well with level 1 PSG and provides a reliable diagnostic tool for OSA, especially in resource-limited settings. However, further validation is required to improve its sensitivity when ruling out OSA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.